ASW

N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide

Find entries where: ASW

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide
Synonyms	Amsacrine
Identifiers	N-[4-(acridin-9-ylamino)-3-methoxy-phenyl]methanesulfonamide
Formula	C₂₁ H₁₉ N₃ O₃ S
Molecular Weight	393.459
Type	NON-POLYMER
Isomeric SMILES	COc1cc(ccc1Nc2c3ccccc3nc4c2cccc4)NS(=O)(=O)C
InChI	InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)
InChIKey	XCPGHVQEEXUHNC-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	47
Chiral Atom Count	0
Bond Count	50
Aromatic Bond Count	22

Drug Info: DrugBank

DrugBank ID	DB00276
Name	Amsacrine
Groups	investigational approved
Description	Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.
Synonyms	Amsacrine Amsacrine gluconate mAMSA Amsacrinum Acridinyl anisidide 4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide m-AMSA 4'-(9-Acridinylamino)methanesulphon-m-anisidide 4'-(9-Acridinylamino)methanesulfon-meta-anisidide Amsacrine hydrochloride Amsacrina 4'-(9-Acridinylamino)methanesulfon-m-anisidide Amsacrine mesylate
Brand Names	Amsa Pd
Indication	For treatment of acute myeloid leukaemia.
Categories	Acridines Aminoacridines Antineoplastic Agents Antineoplastic and Immunomodulating Agents Cardiotoxic antineoplastic agents Compounds used in a research, industrial, or household setting Heterocyclic Compounds, Fused-Ring Immunosuppressive Agents Indicators and Reagents Intercalating Agents Laboratory Chemicals Myelosuppressive Agents Narrow Therapeutic Index Drugs P-glycoprotein inhibitors
ATC-Code	L01XX01
CAS number	51264-14-3

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
DNA	-	unknown	intercalation
DNA topoisomerase 2-alpha	MEVSPLQPVNENMQVNKIKKNEDAKKRLSVERIYQKKTQLEHILLRPDTY...	unknown	inhibitor
Potassium voltage-gated channel subfamily H member 2	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCE...	unknown	inhibitor
Alpha-1-acid glycoprotein 1	MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAF...	unknown
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682